MONDAY, May 19, 2025 (HealthDay News) — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared withContinue Reading

WEDNESDAY, May 14, 2025 (HealthDay News) — More U.S. teenagers are getting weight-loss surgery, despite the discovery of new drugs like Ozempic/Wegovy that help people drop pounds surgery-free, a new study says. Weight loss surgeries for teens increased 15% between 2021 and 2023, researchers reported earlier this month in TheContinue Reading

TUESDAY, May 13, 2025 (HealthDay News) — Cutting-edge weight-loss drugs like Ozempic/Wegovy can cut alcohol intake dramatically in a short amount of time, a new study says. People taking semaglutide or liraglutide reduced their alcohol consumption by two-thirds within four months, according to results recently published in the journal Diabetes,Continue Reading

FRIDAY, May 9, 2025 (HealthDay News) — Childhood obesity nearly triples a person’s risk for experiencing discrimination or stigma based on their weight, a new study says. Severe obesity before age 18 increased a person’s odds of experiencing weight stigma by 2.8 times, researchers reported recently in the International JournalContinue Reading

MONDAY, April 7, 2025 (HealthDay News) — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications. Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid ServicesContinue Reading